TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Major cardiovascular and cerebrovascular adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: The net adverse clinical events
Endpoint domain: Adverse events/effects
Primary endpoint: Prostate Specific Antigen (PSA) kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in average number of night wakings
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Perception of child's sleep problem
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Absolute change in serum LDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mechanically ventilated patient outcome
Endpoint domain: Mortality/survival
Primary endpoint: Range of active movement of the trunk in frontal plane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of active movement of the trunk in sagittal plane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The duration of the march-in-place
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Numerical Rating Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: peritoneal dialysate total white cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Comfort in Dying of Nursing Home Residents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Patients Who Remain Progression-free after Six Months
Endpoint domain: Mortality/survival
Primary endpoint: Numbers of patients with preserved consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Long-term safety data
Endpoint domain: Adverse events/effects
Primary endpoint: 3 years overall survival
Endpoint domain: Mortality/survival
Primary endpoint: Duration of remaining in chronic phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Sperm Cell Count Per Milliliter of Seminal Fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of Sperm Cells With Normal Motility (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of Sperm Cells With Abnormal Morphology (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: % Excess Body Weight Loss (%EWL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Eperisone-HCl in treating acute musculoskeletal spasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ad Libitum Food and Beverage Intake (g)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hedonic Ratings of Food as Measured by a Visual Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Voxel-wise Blood Oxygen Level-Dependent (BOLD) Brain Activation in Response to Milkshake Anticipation and Receipt vs. Water
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serial changes in plasma citrulline level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modification of immunophenotypic characteristics of normal breast tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Rate of Patient Adherence to Exercise Regimen
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of Adverse Events Secondary to Exercises
Endpoint domain: Adverse events/effects
Primary endpoint: Complete EID Retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of adenomatous polyps of the colon and rectum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sensitivity/Specificity to detect endobronchial intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants Prescribed Oral Anticoagulants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of coronary disease greater than 50% diameter stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of target blood glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time of hyperglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hypoglycemia rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Role Functioning Scale
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Heinrichs-Carpenter Quality of Life Scale (QLS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Multidimensional Scale of Perceived Social Support (MSPSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Global Functioning Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction of HBV vertical transmission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: MTX concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biodex balance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECP tear concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression levels measured by Beck Depression Inventory - II (BDI-II)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pressure-time product of the diaphragm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Patient - ventilator asynchrony index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Overall blood pressure control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: H. pylori status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: high-intensity drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alcohol-related problems
Endpoint domain: Adverse events/effects
Primary endpoint: hazardous/harmful drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline cardiovascular capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Malignant potential of P-NETs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of asynchronies during mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to first Skeletal Related Event (SRE)
Endpoint domain: Mortality/survival
Primary endpoint: Depressive symptoms severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: corrected QT dispersion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: vessel caliber
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change From Baseline in Negative Symptom Assessment - 16-item (NSA-16) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: maximum tolerated dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Disease Activity Scale in 28 Joints (DAS-28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of HIT-antibodies
Endpoint domain: Adverse events/effects
Primary endpoint: Intensity of reported flushing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of 3-dose HPV vaccine series
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Help-seeking Behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Primary Care Posttraumatic Stress Disorder (PC-PTSD) Screen
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Moral Injury Events Scale (MIES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Breathing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Plasma C-terminal Telopeptide of Type I Collagen (CTx-1) (% Change From Baseline)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall Response Rate (Partial and Complete Response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADHD Rating Scale-IV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebrovascular complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: maintenance of metabolic control (glycemic durability)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Vaccination rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in postoperative sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Visual Analog Scale for Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in visual attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Undergoing Image-guided Cryoablation
Endpoint domain: Adverse events/effects
Primary endpoint: serum Zn
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ZPP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: number of Emergency Department visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Self-reported sexual functioning
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Self-reported erectile functioning
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Sexual activity scale
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Change from baseline ankle range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Flap surgery outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Neurological and functional scales
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Oral injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experiences of patients with cardiovascular disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of pancreatic fistula grade C
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity and Specificity of 3D tomography-SLI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline sympathetic nerve activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from atrial fibrillation, atrial flutter or atrial tachycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of procedural success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: PASI50 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evidence of adaptive and innate factors/responses during asthma exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Forgotten Joint Score 12
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: plasmablast measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vulvar wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: Dose limiting toxicity events (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Overall bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Summary of Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse cardiac events (MACE)
Endpoint domain: Mortality/survival
Primary endpoint: Requirement for Invasive Mechanical Ventilation
Endpoint domain: Mortality/survival
Primary endpoint: RV/LV Ratio Difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of TB
Endpoint domain: Adverse events/effects
Primary endpoint: Change in length and length-for-age Z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in weight and weight-for-age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of diarrhea and laboratory-confirmed malaria
Endpoint domain: Adverse events/effects
Primary endpoint: Inflammatory lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-point Clinical Erythema Assessment (CEA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-point Patient Severity Assessment of Erythema (PSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High frequency index (HFnu) of heart rate variability (HRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 20% improvement over baseline Visual Analog Scale for Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional magnetic resonance imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the serum iron curve over 8 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the NTBI curve over 8 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the percent transferrin saturation curve over 8 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Outcome Questionnaires relating to the patients current condition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Passive Hip Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Risk of complications of AV fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Return to Baseline Respiratory Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Surgical Completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Apneic Episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Bradycardia Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Frequency of Distress Maintaining Attributions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Extent to Which the Spray Reached Your Expectations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Likelihood to Buy the Product After First Dose
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Interest in Taking the Spray Product Home
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Counseling Center Assessment of Psychological Symptoms-62
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Outcome Questionnaire- 45.2
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mindful Attention and Awareness Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Immediate pain score upon arrival to phase 1 PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adaptation with pregnancy before intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adaptation with pregnancy after intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mother-Neonatal Perception after birth
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adaptation to the postpartum period
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lysosomal movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of Ascites or Pleural Effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intensive care unit admission for any reason
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for antibiotics with hospital readmission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Negative Detection Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histological evaluation of osteotomy sections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean SUV of large arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in TMAO levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in negative and positive affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Circulating blood markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in sustained attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incident AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Progression of AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patterns of organism and resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Genetic relatedness between bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of patients with post-operative wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: Sleep parameters by objective measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep parameters by subjective measures
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: relative bioavailability of azelastine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose of CCI-779
Endpoint domain: Adverse events/effects
Primary endpoint: Composite Responder Rate at Month 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of total injections during study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants Who Require Preemptive HCMV Therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of pharmacies enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of successful breathing and activity measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of pain levels (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in frequency of diabetic ketoacidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum Observed Plasma Analyte Concentration (Cmax) of Tadalafil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve from Time Zero to the Last Quantifiable Concentration (AUC [0-last]) of Tadalafil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve from Time Zero to Infinity (AUC [0-infinity]) of Tadalafil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Analyte Concentration (Cmax) of Tadalafil and Macitentan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PFS rate of 2nd line treatment at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with self-test execution
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Compliance with results interpretation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Compliance with self-test result
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Compliance with self-test steps
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Local recurrence or occurrence of CNS metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Objective response rare (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of use of the booklet and platelets
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of Interstitial lung disease
Endpoint domain: Adverse events/effects
Primary endpoint: Time-weighted Average Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes